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... the preparation
of the manuscript
begins with the
planning of the
project.s an editor, I am frequently asked for insights as to how to get a manuscript
accepted for publication. Implicit in this request is the concept that the
presentation of a manuscript may determine the decision to accept or reject
ndependent of the contents. Also implied is that certain characteristics of the
resentation of a paper markedly enhance the chance of acceptance, and some can be
ery detrimental. Although I am sure that the latter is true, I am very skeptical of the
ormer. In my opinion, much of the credit attributed to presentation is merely a
eflection of good study design and execution. Whereas I agree that a poor presentation
an sink a good study, I do not think an excellent presentation can rescue one that is
atally flawed. Nevertheless, there is a widely held suspicion that the “packaging” of a
tudy is as important as the contents.
The other interesting aspect of the request for advice is the assumption that being an
ditor endows one with near perfection as an investigator/author. Although it is intuitive
hat someone immersed in the evaluation of research should be knowledgeable about the
ubject, critiquing an investigation is different from conceiving and performing it. Just as
eople follow the advice of stock brokers who are often unsuccessful at selecting
rofitable stocks for themselves, so too the experience of evaluating papers does not
ecessarily translate into infallibility in producing them. In fact, I have had and continue
o have papers rejected for publication, and I know the same is true of other editors.
evertheless, the current JACC editors have now processed over 20,000 submissions, and
ver time patterns have emerged and a number of characteristics, both good and bad,
ave been repeatedly observed and catalogued.
I was recently asked to give a lecture at a major meeting on the topic of how to get a
aper accepted in a competitive journal. I approached this by soliciting from each
ssociate editor a list of the 10 most common factors they encountered that led to
he acceptance or rejection of a manuscript. As might be expected, some variability
xisted in their responses; however, a number of themes recurred. The talk was well
eceived, and I was encouraged by attendees to put it into print. Stimulated by this
ncouragement and the frequent requests for insights, I decided to write about the
consensus” opinions of the editors as to the most desirable characteristics of a
anuscript. Because the material is more than one Editor’s Page, this one and the next
ill be devoted to the topic.
The first, and undoubtedly most important, insight that can be provided is that the
reparation of the manuscript begins with the planning of the project. It is axiomatic
hat a well-planned project will inherently address most of the recommendations the
ditors advanced for preparing a research paper. As previously stated, poor presentation
an ruin a great study, but great presentation cannot salvage one that is flawed.
owever, there was also a consensus that presentation could indeed make a difference in
hether a paper is published or rejected. Given our acceptance rate of 10% to 15%,
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... the first and
most important
characteristic we look
for in a manuscript
is novelty.cceptable papers of comparable scientific quality may be distinguished by the caliber of
resentation.
As a general statement, there are three qualities that characterize superior research
apers and are carefully sought out by the editors. We seek manuscripts that are novel
new), accurate (true), and important (clinically or investigationally relevant).
Far and away the first and most important characteristic we look for in a manuscript
s novelty. This, of course, is a difficult attribute to achieve, because there are very few
hings that are truly new “under the sun.” The most desirable expression of novelty is to
e the first report on the subject. However, being the definitive data in a previously
eported area in which controversy exists is also valuable. If a study is neither new nor
efinitive, there is still merit in extending prior findings or presenting the largest study
f the question, although such papers are often critiqued as incremental. The lowest
evel of novelty is the confirmatory study, especially if presented as data from a special
opulation or “in the current era” when there is no reason to believe that the findings
hould differ in that setting.
The second characteristic that is scrutinized is accuracy. It is not that accuracy is less
mportant, but rather it is easier to achieve than novelty and, therefore, more anticipated
o be present. A careful evaluation is done of the characteristics of the study group,
he presence of controls and power calculations, and the specifics of the protocol.
he methodology employed must be capable of answering the question, validated,
eproducible, and sufficiently precise. Confounding variables must be absent. In terms of
arker and genetic/genomic studies, separate validation and prospective confirmation
ohorts are sought.
The final general characteristic that is crucial is the importance, or relevance, of the
ndings. In this regard, studies with implications for management are best, and account
or the “star” quality of the randomized prospective clinical megatrials. In fact, we
enerally give expedited review and publication to studies that impact the management
f disease. Close in importance are studies that develop or validate a method to establish
diagnosis or quantify severity. Papers that have implications for neither therapy nor
iagnostic evaluation often have importance due to establishing mechanisms or defining
rognosis. Obviously, data on prognosis are less relevant for conditions for which no
ffective interventions exist. Finally, editors and reviewers often assign high priority
o manuscripts containing data that are hypothesis-generating. A paper has a fatal
haracteristic if it provokes the question “so what?” after being read.
Surely there is nothing surprising in the aforementioned comments. No one sets out
nowingly to examine a question that has already been answered or is of no importance.
either does anyone purposely use inaccurate methodology. Nevertheless, it is surprising
ow often this actually occurs. Of greater importance, it is noteworthy how often
anuscripts fail to establish and emphasize their novelty, accuracy, and relevance.
nowing that these are the characteristics that are being sought, authors would be
xpected to go to great lengths in the manuscript to establish their presence. To this
nd, in forthcoming Editor’s Pages, I will discuss 10 specific actions, termed “strategies,”
ulled from the opinions of the associate editors to achieve this goal and to produce the
trongest possible manuscript.
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